Clinical Trial Update: Phase II Study of Perindopril and Regorafenib in mCRC [Phase 2]

View source ↗

Summary

Phase II trial of perindopril in combination with regorafenib for metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)
• perindopril (perindopril)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-09-12